Cilostazol Tablet
Product Images NDC 62135-986

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 62135-986). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Cilostazol Tab 100mg 60s Bottle Label)

Cilostazol Tablets USP 100 mg oral tablets, packaged by Chartwell RX, LLC. The label indicates a quantity of 60 tablets, prescription only, with instructions for patient information dispensing. The label features the NDC number 62135-986-60 and includes storage and usage instructions, child-resistant closure notice, and a barcode.*

FDA Label Image

Image Description (Cilostazol Tab 50mg 60s Bottle Label)

The label for Cilostazol Tablets, USP, 50 mg oral tablets, displays the product name, strength, and dosage form prominently. It includes the NDC number 62135-983-60 and states the quantity of 60 tablets. The label specifies the drug is Rx Only and provides storage instructions, handling precautions, and manufacturer information from Chartwell RX, LLC. A barcode and the statement 'No Varnish' are also visible.*

FDA Label Image

Image Description (Cilostazol Tab Figure 1)

A line graph showing plasma concentration (ng/mL) over time (hours) for Cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol. The graph includes three plotted lines representing the concentration decline of each compound from 0 to 24 hours post-dose.*

FDA Label Image

Image Description (Cilostazol Tab Figure 2)

A bar graph showing percent mean improvement in maximal walking distance across eight clinical trials comparing placebo, Cilostazol 50 mg b.i.d., and Cilostazol 100 mg b.i.d. The graph includes trial sample sizes and trial durations of 24, 16, and 12 weeks. Cilostazol 100 mg b.i.d. shows the highest improvement in walking distance in most trials.*

FDA Label Image

Image Description (Cilostazol Tab Structure)

Chemical structure of Cilostazol, shown as a molecular diagram with rings and labeled atoms, representing the active ingredient for this oral tablet prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.